JP2017536367A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2017536367A5 JP2017536367A5 JP2017527204A JP2017527204A JP2017536367A5 JP 2017536367 A5 JP2017536367 A5 JP 2017536367A5 JP 2017527204 A JP2017527204 A JP 2017527204A JP 2017527204 A JP2017527204 A JP 2017527204A JP 2017536367 A5 JP2017536367 A5 JP 2017536367A5
- Authority
- JP
- Japan
- Prior art keywords
- preparation
- percentage
- bound
- less
- fatty acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- TZCPCKNHXULUIY-RGULYWFUSA-N 1,2-distearoyl-sn-glycero-3-phosphoserine Chemical compound CCCCCCCCCCCCCCCCCC(=O)OC[C@H](COP(O)(=O)OC[C@H](N)C(O)=O)OC(=O)CCCCCCCCCCCCCCCCC TZCPCKNHXULUIY-RGULYWFUSA-N 0.000 claims 33
- ZWZWYGMENQVNFU-UHFFFAOYSA-N Glycerophosphorylserin Natural products OC(=O)C(N)COP(O)(=O)OCC(O)CO ZWZWYGMENQVNFU-UHFFFAOYSA-N 0.000 claims 33
- 235000014113 dietary fatty acids Nutrition 0.000 claims 13
- 229930195729 fatty acid Natural products 0.000 claims 13
- 239000000194 fatty acid Substances 0.000 claims 13
- 150000004665 fatty acids Chemical class 0.000 claims 13
- 239000000203 mixture Substances 0.000 claims 13
- 235000013305 food Nutrition 0.000 claims 12
- 235000013376 functional food Nutrition 0.000 claims 12
- 235000016709 nutrition Nutrition 0.000 claims 12
- 235000015872 dietary supplement Nutrition 0.000 claims 10
- 206010003805 Autism Diseases 0.000 claims 8
- 208000020706 Autistic disease Diseases 0.000 claims 8
- 208000030251 communication disease Diseases 0.000 claims 8
- IPCSVZSSVZVIGE-UHFFFAOYSA-N hexadecanoic acid Chemical compound CCCCCCCCCCCCCCCC(O)=O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 claims 8
- MBMBGCFOFBJSGT-KUBAVDMBSA-N all-cis-docosa-4,7,10,13,16,19-hexaenoic acid Chemical compound CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCC(O)=O MBMBGCFOFBJSGT-KUBAVDMBSA-N 0.000 claims 6
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 claims 4
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 claims 4
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 claims 4
- 208000030979 Language Development disease Diseases 0.000 claims 4
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 claims 4
- 239000005642 Oleic acid Substances 0.000 claims 4
- 235000021314 Palmitic acid Nutrition 0.000 claims 4
- JAZBEHYOTPTENJ-JLNKQSITSA-N all-cis-5,8,11,14,17-icosapentaenoic acid Chemical compound CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCCC(O)=O JAZBEHYOTPTENJ-JLNKQSITSA-N 0.000 claims 4
- 208000029560 autism spectrum disease Diseases 0.000 claims 4
- 235000020669 docosahexaenoic acid Nutrition 0.000 claims 4
- 235000020673 eicosapentaenoic acid Nutrition 0.000 claims 4
- 229960005135 eicosapentaenoic acid Drugs 0.000 claims 4
- JAZBEHYOTPTENJ-UHFFFAOYSA-N eicosapentaenoic acid Natural products CCC=CCC=CCC=CCC=CCC=CCCCC(O)=O JAZBEHYOTPTENJ-UHFFFAOYSA-N 0.000 claims 4
- 230000002996 emotional effect Effects 0.000 claims 4
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 claims 4
- WQEPLUUGTLDZJY-UHFFFAOYSA-N n-Pentadecanoic acid Natural products CCCCCCCCCCCCCCC(O)=O WQEPLUUGTLDZJY-UHFFFAOYSA-N 0.000 claims 4
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 claims 4
- WTJKGGKOPKCXLL-RRHRGVEJSA-N phosphatidylcholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCCCCCCC=CCCCCCCCC WTJKGGKOPKCXLL-RRHRGVEJSA-N 0.000 claims 4
- PORPENFLTBBHSG-MGBGTMOVSA-N 1,2-dihexadecanoyl-sn-glycerol-3-phosphate Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP(O)(O)=O)OC(=O)CCCCCCCCCCCCCCC PORPENFLTBBHSG-MGBGTMOVSA-N 0.000 claims 3
- WRGQSWVCFNIUNZ-GDCKJWNLSA-N 1-oleoyl-sn-glycerol 3-phosphate Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OC[C@@H](O)COP(O)(O)=O WRGQSWVCFNIUNZ-GDCKJWNLSA-N 0.000 claims 3
- OYHQOLUKZRVURQ-HZJYTTRNSA-N Linoleic acid Chemical compound CCCCC\C=C/C\C=C/CCCCCCCC(O)=O OYHQOLUKZRVURQ-HZJYTTRNSA-N 0.000 claims 3
- AWUCVROLDVIAJX-UHFFFAOYSA-N alpha-glycerophosphate Natural products OCC(O)COP(O)(O)=O AWUCVROLDVIAJX-UHFFFAOYSA-N 0.000 claims 3
- 229940090949 docosahexaenoic acid Drugs 0.000 claims 3
- 235000020778 linoleic acid Nutrition 0.000 claims 3
- OYHQOLUKZRVURQ-IXWMQOLASA-N linoleic acid Natural products CCCCC\C=C/C\C=C\CCCCCCCC(O)=O OYHQOLUKZRVURQ-IXWMQOLASA-N 0.000 claims 3
- 150000003904 phospholipids Chemical class 0.000 claims 3
- 208000036640 Asperger disease Diseases 0.000 claims 2
- 201000006062 Asperger syndrome Diseases 0.000 claims 2
- 239000002417 nutraceutical Substances 0.000 claims 2
- 235000021436 nutraceutical agent Nutrition 0.000 claims 2
- 239000008194 pharmaceutical composition Substances 0.000 claims 2
- DVSZKTAMJJTWFG-SKCDLICFSA-N (2e,4e,6e,8e,10e,12e)-docosa-2,4,6,8,10,12-hexaenoic acid Chemical compound CCCCCCCCC\C=C\C=C\C=C\C=C\C=C\C=C\C(O)=O DVSZKTAMJJTWFG-SKCDLICFSA-N 0.000 claims 1
- GZJLLYHBALOKEX-UHFFFAOYSA-N 6-Ketone, O18-Me-Ussuriedine Natural products CC=CCC=CCC=CCC=CCC=CCC=CCCCC(O)=O GZJLLYHBALOKEX-UHFFFAOYSA-N 0.000 claims 1
- 239000013543 active substance Substances 0.000 claims 1
- 230000006735 deficit Effects 0.000 claims 1
- KAUVQQXNCKESLC-UHFFFAOYSA-N docosahexaenoic acid (DHA) Natural products COC(=O)C(C)NOCC1=CC=CC=C1 KAUVQQXNCKESLC-UHFFFAOYSA-N 0.000 claims 1
- 238000002560 therapeutic procedure Methods 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201462082261P | 2014-11-20 | 2014-11-20 | |
| US62/082,261 | 2014-11-20 | ||
| PCT/IB2015/002391 WO2016079595A2 (en) | 2014-11-20 | 2015-11-19 | Phospholipid preparations for the improvement of communication skills |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2017536367A JP2017536367A (ja) | 2017-12-07 |
| JP2017536367A5 true JP2017536367A5 (enExample) | 2018-12-27 |
| JP6787891B2 JP6787891B2 (ja) | 2020-11-18 |
Family
ID=54337183
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2017527204A Active JP6787891B2 (ja) | 2014-11-20 | 2015-11-19 | コミュニケーションスキルの改善のためのリン脂質調製物 |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US20170360812A1 (enExample) |
| EP (1) | EP3220753B1 (enExample) |
| JP (1) | JP6787891B2 (enExample) |
| KR (1) | KR102409134B1 (enExample) |
| CN (1) | CN107249581B (enExample) |
| AU (1) | AU2015348010B2 (enExample) |
| CA (1) | CA2967895C (enExample) |
| ES (1) | ES2745226T3 (enExample) |
| IL (1) | IL252302B (enExample) |
| NZ (1) | NZ733019A (enExample) |
| SG (1) | SG11201703944XA (enExample) |
| WO (1) | WO2016079595A2 (enExample) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN117918425B (zh) * | 2024-03-05 | 2025-01-24 | 广州迪卡德营养科技有限公司 | 一种提高记忆学习功能的神经酸组合物及其制备方法 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE10149108A1 (de) * | 2001-10-05 | 2003-04-30 | Degussa Bioactives Deutschland | Verwendung von Phosphatidylserin zur Behandlung des Aufmerksamkeits-Defizit-Syndroms (ADHS) |
| US7935365B2 (en) * | 2003-10-22 | 2011-05-03 | Enzymotec, Ltd. | Glycerophospholipids for the improvement of cognitive functions |
| IL158552A0 (en) | 2003-10-22 | 2004-05-12 | Enzymotec Ltd | Lipids containing omega-3 fatty acids |
| IL158553A0 (en) | 2003-10-22 | 2004-05-12 | Enzymotec Ltd | Method for preparing phosphatidylserine containing omega-3 acid moieties |
| DK1559430T3 (da) * | 2004-01-29 | 2009-07-20 | Indena Spa | Anvendelse af Ginkgo-komplekser til forstærkning af kognitive funktioner og lindring af mental træthed |
| KR20120051458A (ko) * | 2010-11-12 | 2012-05-22 | 주식회사 두산 | 크릴 인지질을 이용하여 아스타잔틴 및 ｄｈａ－ 및/또는 ｅｐａ－결합된 포스파티딜세린을 함유한 조성물을 제조하는 방법 및 이러한 방법에 의해 제조된 조성물 |
| US10052319B2 (en) * | 2012-04-26 | 2018-08-21 | Sumitomo Dainippon Pharma Co., Ltd. | Medicament for treating mental and behavioural disorders |
| JP6291058B2 (ja) * | 2013-12-05 | 2018-03-14 | エンザイモテック リミティド | セリングリセロリン脂質調製物及び発作の治療方法 |
-
2015
- 2015-11-19 AU AU2015348010A patent/AU2015348010B2/en active Active
- 2015-11-19 EP EP15831064.9A patent/EP3220753B1/en active Active
- 2015-11-19 KR KR1020177016965A patent/KR102409134B1/ko active Active
- 2015-11-19 SG SG11201703944XA patent/SG11201703944XA/en unknown
- 2015-11-19 US US15/527,190 patent/US20170360812A1/en not_active Abandoned
- 2015-11-19 WO PCT/IB2015/002391 patent/WO2016079595A2/en not_active Ceased
- 2015-11-19 CA CA2967895A patent/CA2967895C/en active Active
- 2015-11-19 JP JP2017527204A patent/JP6787891B2/ja active Active
- 2015-11-19 ES ES15831064T patent/ES2745226T3/es active Active
- 2015-11-19 NZ NZ733019A patent/NZ733019A/en unknown
- 2015-11-19 CN CN201580074110.5A patent/CN107249581B/zh active Active
-
2017
- 2017-05-15 IL IL252302A patent/IL252302B/en active IP Right Grant
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP6368306B2 (ja) | 炎症性腸疾患（ｉｂｄ）患者の筋骨格の健康を促進させるための栄養組成物 | |
| MY189576A (en) | Omega-3 fatty acid ester compositions | |
| WO2014011895A3 (en) | High solubility acid salts, intravenous dosage forms, nutrition supplementation and methods of use thereof | |
| HK1206248A1 (en) | Compositions of statins and omega-3 fatty acids | |
| NZ600167A (en) | Concentrated therapeutic phospholipid compositions | |
| WO2008147562A3 (en) | Dietary formulations and methods for treatment of inflammation and other disorders | |
| JP2022542513A (ja) | ω－３脂肪酸塩とボスウェリア種由来のガム樹脂の抽出物とを含む調製物 | |
| ES2643843T3 (es) | Aplicación terapéutica de aceite de kril por vía parenteral | |
| JP2014508156A5 (enExample) | ||
| WO2005089744A3 (en) | Use of docosatrienes, resolvins and their stable analogs in the treatment of airway diseases and asthma | |
| WO2012013331A3 (en) | Capsules of active pharmaceutical ingredients and polyunsaturated fatty acids for the treatment of prostate diseases | |
| WO2011097273A8 (en) | Methods and compositions for treating non-alcoholic fatty liver disease with docosahexaenoic acid and n-acetyl l-cysteine | |
| HRP20190461T1 (hr) | Čvrsti pripravak koji sadrži željezo, namijenjen upotrebi kod stanja s nedostatkom željeza | |
| JP2014505702A5 (enExample) | ||
| WO2011097276A8 (en) | Methods and compositions for treating arthritis with docosahexaenoic acid | |
| MX2018000143A (es) | Composiciones nutritivas que contienen fosfatidiletanolamina, esfingomielina y acido docosahexaenoico. | |
| Vázquez et al. | Bioactive lipids | |
| JP2014517028A5 (enExample) | ||
| WO2006078457A3 (en) | Use of resolvins to treat gastrointestinal diseases | |
| RU2017129161A (ru) | Композиции липидов | |
| CN105705025B (zh) | 包含十八碳四烯酸和橄榄油的食用脂质组合物 | |
| EP3762006B1 (en) | Krill oil for solubilizing poorly water-soluble dietary supplements and pharmaceutically active agents | |
| WO2011137160A3 (en) | Composition and method to improve blood lipid profiles and optionally reduce low density lipoprotein (ldl) per-oxidation in humans | |
| JP2017536367A5 (enExample) | ||
| JP2019534329A5 (enExample) |